Wednesday, February 10, 2010, 4:30am EST - Canadian Markets open in 5 hours.
To create a watchlist or portfolio of shares, Sign-in or Register

IR Biosciences Holdings Inc. (IRBS.OB)

On Feb 9: 0.35 USD   0.00 (0.00%)  
MORE ON IRBS.OB
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials
Headlines Get Headlines for:
Wed, Jan 27, 2010
National Cancer Institute Initiates Studies on ImmuneRegen BioSciences' Vaccine Adjuvant Candidate
Marketwire (Wed, Jan 27)
Tue, Jan 26, 2010
IR Biosciences' ImmuneRegen (OTCBB: IRBS) Getting Attention for Its Adult Stem Cell Active Compound
Marketwire (Tue, Jan 26)
Tue, Jan 5, 2010
ImmuneRegen BioSciences(R) Reports Additional Positive Results From Study of Homspera(R) in Treating Highly Pathogenic Influenza
Marketwire (Tue, Jan 5)
Thu, Dec 24, 2009
ImmuneRegen BioSciences(R) Summarizes Previous 9 Months of Advances as Homspera(R) Development Continues
Marketwire (Thu, Dec 24)
Mon, Dec 21, 2009
ImmuneRegen BioSciences'(R) Reports Efficacy of a New Adjuvant of a Preventive Cancer Vaccine
Marketwire (Mon, Dec 21)
Mon, Dec 14, 2009
ImmuneRegen BioSciences'(R) Drug Candidate Homspera Confirms Efficacy as Cancer Vaccine Adjuvant
Marketwire (Mon, Dec 14)
Sat, Nov 21, 2009
IR BIOSCIENCES HOLDINGS INC Financials
EDGAR Online Financials (Sat, Nov 21)
Mon, Nov 16, 2009
IR BIOSCIENCES HOLDINGS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 16)
Tue, Nov 10, 2009
ImmuneRegen BioSciences(R) Reports Positive Results of Homspera(R) in Treating Highly Pathogenic Influenza
Marketwire (Tue, Nov 10)
Thu, Oct 22, 2009
ImmuneRegen BioSciences(R) to Further Homspera(R) Research in Study Funded by U.S. Government
Marketwire (Thu, Oct 22)
Mon, Oct 12, 2009
ImmuneRegen BioSciences(R) Initiates Homspera(R) Studies Against Global Influenza Threat
Marketwire (Mon, Oct 12)
Wed, Sep 23, 2009
ImmuneRegen BioSciences(R) Announces Strategic Partnership With Azopharma Product Development Group, Inc.
Marketwire (Wed, Sep 23)
Tue, Sep 22, 2009
ImmuneRegen BioSciences(R) Announces Partnership With Bachem, Inc., for Manufacturing of Homspera(R)
Marketwire (Tue, Sep 22)
Wed, Sep 9, 2009
ImmuneRegen BioSciences(R) Partners With University of Rochester in BARDA Funding Bid
Marketwire (Wed, Sep 9)
Wed, Aug 26, 2009
ImmuneRegen BioSciences(R) Announces Collaboration With Archimedes Development Limited
Marketwire (Wed, Aug 26)
Fri, Aug 14, 2009
IR BIOSCIENCES HOLDINGS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Aug 14)
Wed, Jul 8, 2009
IR BIOSCIENCES HOLDINGS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
EDGAR Online (Wed, Jul 8)
Tue, Jun 9, 2009
IR BIOSCIENCES HOLDINGS INC Files SEC form 8-K, Regulation FD Disclosure
EDGAR Online (Tue, Jun 9)
Thu, May 28, 2009
ImmuneRegen BioSciences Announces IND Submission for Homspera(R) for the Treatment of Idiopathic Pulmonary Fibrosis
Marketwire (Thu, May 28)
Fri, May 15, 2009
IR BIOSCIENCES HOLDINGS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, May 15)
Older Headlines
View headlines from:

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Headlines for Another Symbol:
Symbol Lookup
Latest News Canadian Indices